<?xml version="1.0" encoding="ISO-8859-1"?>


<!DOCTYPE publicwhip
[
<!ENTITY ndash   "&#8211;">
<!ENTITY mdash   "&#8212;">
<!ENTITY iexcl   "&#161;">
<!ENTITY divide  "&#247;">
<!ENTITY euro    "&#8364;">
<!ENTITY trade   "&#8482;">
<!ENTITY bull    "&#8226;">
<!ENTITY lsquo   "&#8216;">
<!ENTITY rsquo   "&#8217;">
<!ENTITY sbquo   "&#8218;">
<!ENTITY ldquo   "&#8220;">
<!ENTITY rdquo   "&#8221;">
<!ENTITY bdquo   "&#8222;">
<!ENTITY dagger  "&#8224;">

<!ENTITY Ouml   "&#214;" >
<!ENTITY szlig  "&#223;" >
<!ENTITY agrave "&#224;" >
<!ENTITY aacute "&#225;" >
<!ENTITY acirc  "&#226;" >
<!ENTITY atilde "&#227;" >
<!ENTITY auml   "&#228;" >
<!ENTITY ccedil "&#231;" >
<!ENTITY egrave "&#232;" >
<!ENTITY eacute "&#233;" >
<!ENTITY ecirc  "&#234;" >
<!ENTITY euml   "&#235;" >
<!ENTITY iacute "&#237;" >
<!ENTITY icirc  "&#238;" >
<!ENTITY iuml	"&#239;" >
<!ENTITY ntilde "&#241;" >
<!ENTITY nbsp   "&#160;" >
<!ENTITY oacute "&#243;" >
<!ENTITY ocirc  "&#244;" >
<!ENTITY ouml   "&#246;" >
<!ENTITY oslash "&#248;" >
<!ENTITY uacute "&#250;" >
<!ENTITY uuml   "&#252;" >
<!ENTITY thorn  "&#254;" >

<!ENTITY pound  "&#163;" >
<!ENTITY sect   "&#167;" >
<!ENTITY copy   "&#169;" >
<!ENTITY reg    "&#174;" >
<!ENTITY deg    "&#176;" >
<!ENTITY plusmn "&#177;" >
<!ENTITY sup2   "&#178;" >
<!ENTITY micro  "&#181;" >
<!ENTITY para   "&#182;" >
<!ENTITY middot "&#183;" >
<!ENTITY ordm   "&#186;" >
<!ENTITY frac14 "&#188;" >
<!ENTITY frac12 "&#189;" >
<!ENTITY frac34 "&#190;" >
<!ENTITY oelig "&#339;" >
<!ENTITY aelig  "&#230;" >

]>

<publicwhip scrapeversion="a" latest="yes">

<minor-heading id="uk.org.publicwhip/wrans/2010-10-07a.23.0" nospeaker="true" colnum="23"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000450">
	Companies: Universities
</minor-heading>

<ques id="uk.org.publicwhip/wrans/2010-10-07a.23.1" speakerid="uk.org.publicwhip/lord/100817" speakername="Lord Triesman" colon=":" colnum="23"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000450">
	<p pid="a.23.1/1" qnum="HL2181">To ask Her Majesty's Government whether, including reverse takeovers as acquisitions, any companies spun out of United Kingdom universities since 2003-04 have been acquired since then; and, if so, what were their (a) original and current names, and (b) flotation and sale values.</p>
	<p pid="a.23.1/2" qnum="HL2182">To ask Her Majesty's Government, for each company spun out of United Kingdom universities for the years 2002-03 to 2009-10, what was (a) the name of the company, (b) the university from which the spin out occurred, (c) the market in which it is quoted, (d) the original flotation value, (e) the cash raised by the flotation, (f) the date of the flotation, (g) the stock market symbol for each company, (h) the market capital at 1 September 2010, and (i) the percentage increase in value between the original flotation and the market capital value at 1 September 2010.</p>
</ques>

<reply id="uk.org.publicwhip/wrans/2010-10-07a.24.0" speakerid="uk.org.publicwhip/lord/100684" speakername="Baroness Wilcox" colon=":" colnum="24"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000003">
	<p pid="a.24.0/1">Companies, including spin-outs, are required to comply with a number of formal reporting and accounting requirements. Information on individual university spin-out companies or their subsequent financial performance is not collected separately.</p>
	<p pid="a.24.0/2">The annual Higher Education-Business and Community Interaction (HE-BCI) Survey provides information about UK universities commercialisation activities, including the number of spin-outs created each year. The HE-BCI Survey 2008-09 is available at <a href="http://www.hesa.ac.uk">http://www.hesa.ac.uk</a>.</p>
	<p pid="a.24.0/3">PraxisUnico compiles information from publicly available sources about university spin-out companies. This data indicates that between 2003 and 2010, 38 university spin-outs were floated on the stock exchange with an IPO value of &#163;l.77 billion, and 24 university spin-out companies were acquired by other business for a total value in excess of &#163;2.6 billion.</p>
	<p pid="a.24.0/4">The collated data from PraxisUnico is set out in the tables below:</p>
	<table>
		<tbody>
			<tr pid="a.24.0/7"> <td colspan="7"><I>Table 1: University Spin-out Company Flotations</I></td> </tr>
			<tr pid="a.24.0/8"> <td>Company</td> <td>University</td> <td>Initial Market</td> <td>IPO Value</td> <td>Money raised</td> <td>Date of Launch</td> <td>Ticker</td> </tr>
			<tr pid="a.24.0/9"> <td>Wolfson Micro</td> <td>Edinburgh</td> <td>LSE</td> <td>&#163;214m</td> <td>&#163;25.3m</td> <td>Oct-03</td> <td>WLF.L</td> </tr>
			<tr pid="a.24.0/10"> <td>ARK Therapeutics</td> <td>UCL</td> <td>LSE</td> <td>&#163;168m</td> <td>&#163;55m</td> <td>Mar-04</td> <td>AKT.L</td> </tr>
			<tr pid="a.24.0/11"> <td>OHM</td> <td>Southampton</td> <td>AiM</td> <td>&#163;49m</td> <td>&#163;10m</td> <td>Mar-04</td> <td>OHM</td> </tr>
			<tr pid="a.24.0/12"> <td>Vectura</td> <td>Bath</td> <td>AiM</td> <td>&#163;60m</td> <td>&#163;20.1m</td> <td>Jun-04</td> <td>VEC.L</td> </tr>
			<tr pid="a.24.0/13"> <td>Summit</td> <td>Oxford</td> <td>AiM</td> <td>&#163;42m</td> <td>&#163;15m</td> <td>Oct-04</td> <td>SUMM</td> </tr>
			<tr pid="a.24.0/14"> <td>Synairgen</td> <td>Southampton</td> <td>AiM</td> <td>&#163;28m</td> <td>&#163;10.5m</td> <td>Oct-04</td> <td>SNG</td> </tr>
			<tr pid="a.24.0/15"> <td>Ceres Power</td> <td>Imperial</td> <td>AiM</td> <td>&#163;66m</td> <td>&#163;21.6m</td> <td>Nov-04</td> <td>CWR.L</td> </tr>
			<tr pid="a.24.0/16"> <td>IDMos</td> <td>Dundee/St Andrews</td> <td>AiM</td> <td>&#163;20m</td> <td>&#163;5m</td> <td>Nov-04</td> <td>IDO</td> </tr>
			<tr pid="a.24.0/17"> <td>Microemissive Displays</td> <td>Edinburgh/Napier</td> <td>AiM</td> <td>&#163;25.7m</td> <td>&#163;15.7m</td> <td>Dec-04</td> <td>MED</td> </tr>
			<tr pid="a.24.0/18"> <td>Andor</td> <td>Queen's Belfast</td> <td>AiM</td> <td>&#163;23m</td> <td>&#163;4.5m</td> <td>Dec-04</td> <td>AND</td> </tr>
			<tr pid="a.24.0/19"> <td>Cambridge Display Technology</td> <td>Cambridge</td> <td>NASDAQ</td> <td>$234m <I>(&#163;122m)</I></td> <td>&#163;15.6m</td> <td>Dec-04</td> <td>OLED</td> </tr>
			<tr pid="a.24.0/20"> <td>Fusion IP</td> <td>Sheffield/ Cardiff</td> <td>AiM</td> <td>&#163;43m</td> <td>&#163;8.2m</td> <td>Jan-05</td> <td>FIP</td> </tr>
			<tr pid="a.24.0/21"> <td>Proximagen</td> <td>KCL</td> <td>AiM</td> <td>&#163;29.7m</td> <td>&#163;14.5m</td> <td>Mar-05</td> <td>PRX</td> </tr>
			<tr pid="a.24.0/22"> <td>Provexis</td> <td>Rowett Research Institute</td> <td>AiM<sup>1</sup></td> <td>&#163;14m</td> <td>&#163;5.9m<sup>2</sup></td> <td>Jun-05</td> <td>PXS</td> </tr>
			<tr pid="a.24.0/23"> <td>Stem Cell Sciences</td> <td>Edinburgh</td> <td>AiM<sup>3</sup><sup>-</sup></td> <td>&#163;21.2m</td> <td>&#163;6.0m</td> <td>Jul-05</td> <td>STEM</td> </tr>
			<tr pid="a.24.0/24"> <td>Oxonica</td> <td>Oxford</td> <td>AiM</td> <td>&#163;35.3m</td> <td>&#163;7.1m</td> <td>Jul-05</td> <td>OXN</td> </tr>
			<tr pid="a.24.0/25"> <td>ReNeuron</td> <td>KCL</td> <td>AiM</td> <td>&#163;23.4m</td> <td>&#163;9.5m</td> <td>Aug-05</td> <td>RENE</td> </tr>
			<tr pid="a.24.0/26"> <td>NeuroDiscovery</td> <td>Warwick</td> <td>Australian</td> <td>&#163;3.1m<sup>4</sup></td> <td>&#163;0.63m</td> <td>Aug-05</td> <td>NDL</td> </tr>
			<tr pid="a.24.0/27"> <td>GETECH</td> <td>Leeds</td> <td>AiM</td> <td>&#163;10.8m</td> <td>&#163;3.5m</td> <td>Sep-05</td> <td>GTC</td> </tr>
			<tr pid="a.24.0/28"> <td>SPI Lasers</td> <td>Southampton</td> <td>AiM</td> <td>&#163;25.5m</td> <td>&#163;12m</td> <td>Oct-05</td> <td>SPIL</td> </tr>
			<tr pid="a.24.0/29"> <td>Celoxica</td> <td>Oxford</td> <td>AiM</td> <td>&#163;16.1m</td> <td>&#163;6.1m</td> <td>Oct-05</td> <td>CXA</td> </tr>
			<tr pid="a.24.0/30"> <td>Toumaz <sup>c</sup></td> <td>Imperial College</td> <td>AiM</td> <td>&#163;17.7m</td> <td>&#163;7.1m</td> <td>Nov-05</td> <td>TMZ</td> </tr>
			<tr pid="a.24.0/31"> <td>Lipoxen</td> <td>School Of Pharmacy, London</td> <td>AiM</td> <td>&#163;13.2m</td> <td>&#163;3.78m</td> <td>Jan-06</td> <td>LPX</td> </tr>
			<tr pid="a.24.0/32"> <td>Syntopix</td> <td>Leeds</td> <td>AiM</td> <td>&#163;10.1m</td> <td>&#163;4.0m</td> <td>Mar-06</td> <td>SYN</td> </tr>
			<tr pid="a.24.0/33"> <td>ParOS</td> <td>Imperial</td> <td>AiM</td> <td>&#163;16.5m</td> <td>-</td> <td>Mar-06</td> <td>PARO</td> </tr>
			<tr pid="a.24.0/34"> <td>Renovo</td> <td>Manchester</td> <td>LSE</td> <td>&#163;154m</td> <td>&#163;50m</td> <td>Apr-06</td> <td>RNVO</td> </tr>
			<tr pid="a.24.0/35"> <td>Oxford Catalysts</td> <td>Oxford</td> <td>AiM</td> <td>&#163;65m</td> <td>&#163;15m</td> <td>Apr-06</td> <td>OCG.L</td> </tr>
			<tr pid="a.24.0/36"> <td>Avacta</td> <td>Leeds</td> <td>AiM <sup>6</sup></td> <td>&#163;15m</td> <td>&#163;1.013m</td> <td>Jul-06</td> <td>AVCT</td> </tr>
			<tr pid="a.24.0/37"> <td>Imperial Innovations</td> <td>Imperial</td> <td>AiM</td> <td>&#163;180.8m</td> <td>&#163;25m</td> <td>Jul-06</td> <td>IVO</td> </tr>
			<tr pid="a.24.0/38"> <td>ValiRx</td> <td>Imperial</td> <td>AiM</td> <td>&#163;12.8m</td> <td>-</td> <td>Oct-06</td> <td>VAL</td> </tr>
			<tr pid="a.24.0/39"> <td>Epistem</td> <td>Manchester</td> <td>AiM</td> <td>&#163;8.1m</td> <td>&#163;3m</td> <td>Apr-07</td> <td>EHP</td> </tr>
			<tr pid="a.24.0/40"> <td>Modern Water</td> <td>Surrey/Cardiff</td> <td>AiM</td> <td>&#163;70m</td> <td>&#163;30m</td> <td>Jun-07</td> <td>MWG</td> </tr>
			<tr pid="a.24.0/41"> <td>Tracsis</td> <td>Leeds</td> <td>AiM</td> <td>&#163;7m</td> <td>&#163;2m</td> <td>Nov-07</td> <td>TRCS</td> </tr>
			<tr pid="a.24.0/42"> <td>e-Therapeutics</td> <td>Newcastle</td> <td>AiM</td> <td>&#163;37.3m</td> <td>&#163;1.3m</td> <td>Nov-07</td> <td>ETX</td> </tr>
			<tr pid="a.24.0/43"> <td>Oxford Advanced Surfaces Group</td> <td>Oxford</td> <td>AiM</td> <td>&#163;44.5m</td> <td>&#163;3m</td> <td>Dec-07</td> <td>OXA</td> </tr>
			<tr pid="a.24.0/44"> <td>Nanoco Group</td> <td>Manchester</td> <td>AiM</td> <td>&#163;38.6m</td> <td>&#163;8.1m</td> <td>May-09</td> <td>NANO</td> </tr>
			<tr pid="a.24.0/45"> <td>Ilika</td> <td>Southampton</td> <td>AIM</td> <td>&#163;18.7m</td> <td>&#163;5.2m</td> <td>May-10</td> <td>IKA</td> </tr>
			<tr pid="a.24.0/46"> <td>Tissue Regenix <sup>7</sup></td> <td>Leeds</td> <td>AiM</td> <td>&#163;23.3m</td> <td>&#163;4.5m</td> <td>Jun-10</td> <td>TRX</td> </tr>
			<tr pid="a.24.0/47"> <td>Total</td> <td></td> <td></td> <td>&#163;1772.4m</td> <td>&#163;434.7m</td> <td></td> <td></td> </tr>
		</tbody>
	</table>
	<p pid="a.24.0/50" class="indent">1 Reverse merger with Nutrinnovator plc</p>
	<p pid="a.24.0/51" class="indent">2 &#163;3.8m raised plus &#163;2.1m loan for equity swap</p>
	<p pid="a.24.0/52" class="indent">3 Now on NASDAQ</p>
	<p pid="a.24.0/53" class="indent">4 At A$1 = 42.5p</p>
	<p pid="a.24.0/54" class="indent">4 Reverse merger with Nanoscience plc</p>
	<p pid="a.24.0/55" class="indent">5 Reverse takeover of Readybuy plc</p>
	<p pid="a.24.0/56" class="indent">6 Reverse takeover of Oxeco</p>
	<table>
		<tbody>
			<tr pid="a.24.0/59"> <td colspan="5"><I>Table 2: University Spin-out Company Take-overs</I></td> </tr>
			<tr pid="a.24.0/60"> <td>Acquisitions</td> <td>University</td> <td>Acquirer</td> <td>Price</td> <td>Date</td> </tr>
			<tr pid="a.24.0/61"> <td>Kudos Pharma</td> <td>Cambridge/CRT</td> <td>Astra Zeneca</td> <td>&#163;121 m</td> <td>Dec - 2005</td> </tr>
			<tr pid="a.24.0/62"> <td>NeuTech</td> <td>Manchester</td> <td>Novartis</td> <td>&#163;305.1m</td> <td>Jun - 2006</td> </tr>
			<tr pid="a.24.0/63"> <td>Cambridge Antibody Technology</td> <td>MRC</td> <td>Astra Zeneca</td> <td>&#163;702m<sup>1</sup></td> <td>Aug -2006</td> </tr>
			<tr pid="a.24.0/64"> <td>Domantis</td> <td>MRC</td> <td>GSK</td> <td>&#163;230m</td> <td>Dec -2006</td> </tr>
			<tr pid="a.24.0/65"> <td>Solexa</td> <td>Cambridge</td> <td>Illumina</td> <td>&#163;306m ($600m))</td> <td>Jan - 2007</td> </tr>
			<tr pid="a.24.0/66"> <td>Arrow Therapeutics</td> <td>UCL/Newcastle</td> <td>Astra Zeneca</td> <td>&#163;76m ($150m)</td> <td>Feb - 2007</td> </tr>
			<tr pid="a.24.0/67"> <td>Daniolabs</td> <td>Cambridge</td> <td>VASTox</td> <td>&#163;15m</td> <td>Mar - 2007</td> </tr>
			<tr pid="a.24.0/68"> <td>Plasso Technology</td> <td>Sheffield</td> <td>BD</td> <td>Not disclosed</td> <td>May - 2007</td> </tr>
			<tr pid="a.24.0/69"> <td>MTEM</td> <td>Edinburgh</td> <td>Petroleum Geo-Services</td> <td>&#163;138m ($275m)</td> <td>Jun - 2007</td> </tr>
			<tr pid="a.24.0/70"> <td>Cambridge Display Technology</td> <td>Cambridge</td> <td>Sumitomo</td> <td>&#163;140m ($285m)</td> <td>Jul - 2007</td> </tr>
			<tr pid="a.24.0/71"> <td>Meridio</td> <td>Queens Belfast</td> <td>Autonomy</td> <td>&#163;20m</td> <td>Nov - 2007</td> </tr>
			<tr pid="a.24.0/72"> <td>CamFPD</td> <td>Cambridge</td> <td>Microsoft</td> <td>&#163;l0m</td> <td>Nov - 2007</td> </tr>
			<tr pid="a.24.0/73"> <td>OMD</td> <td>Oxford</td> <td>Avacta</td> <td>&#163;3m</td> <td>Nov - 2007</td> </tr>
			<tr pid="a.24.0/74"> <td>SIW</td> <td>UCL</td> <td>MDY Healthcare</td> <td>&#163;12.5m</td> <td>Feb - 2008</td> </tr>
			<tr pid="a.24.0/75"> <td>Transitive</td> <td>Manchester</td> <td>IBM</td> <td>Not disclosed</td> <td>Dec - 2008</td> </tr>
			<tr pid="a.24.0/76"> <td>Thiakis</td> <td>Imperial</td> <td>Wyeth (Pfizer)</td> <td>&#163;99.6m</td> <td>Dec - 2008</td> </tr>
			<tr pid="a.24.0/77"> <td>Phototherapeutics</td> <td>Manchester</td> <td>Photomedex Inc</td> <td>&#163;14m ($20m)</td> <td>Feb - 2009</td> </tr>
			<tr pid="a.24.0/78"> <td>APT</td> <td>Queens Belfast</td> <td>Audemat</td> <td>Not disclosed</td> <td>Mar - 2009</td> </tr>
			<tr pid="a.24.0/79"> <td>Inforsense</td> <td>Imperial</td> <td>IDBS</td> <td>&#163;5m</td> <td>Jun - 2009</td> </tr>
			<tr pid="a.24.0/80"> <td>BioAnaLab</td> <td>Oxford</td> <td>Millipore</td> <td>Not disclosed</td> <td>Jul - 2009</td> </tr>
			<tr pid="a.24.0/81"> <td>Orthomemetics</td> <td>Cambridge/MIT</td> <td>TiGenix</td> <td>&#163;14.9m (&#8364;16.3m)</td> <td>Dec - 2009</td> </tr>
			<tr pid="a.24.0/82"> <td>Reactivelab</td> <td>Glasgow</td> <td>Avacta</td> <td>&#163;5m</td> <td>Mar -2010</td> </tr>
			<tr pid="a.24.0/83"> <td>Apatech</td> <td>QMU</td> <td>Baxter</td> <td>&#163;220m ($330m)</td> <td>Mar -2010</td> </tr>
			<tr pid="a.24.0/84"> <td>MET</td> <td>Imperial</td> <td>Evonik Industries AG</td> <td>&#163;4.5m</td> <td>Mar - 2010</td> </tr>
			<tr pid="a.24.0/85"> <td>Total</td> <td></td> <td></td> <td>&#163;2591.6m</td> <td></td> </tr>
		</tbody>
	</table>
	<p pid="a.24.0/88" class="indent">1 Astra Zeneca already owned 19.2 per cent of CAT and paid &#163;567 million to acquire the remaining 80.8 per cent of the company.</p>
</reply>

<minor-heading id="uk.org.publicwhip/wrans/2010-10-07a.26.0" nospeaker="true" colnum="26"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000451">
	Education: Languages
</minor-heading>

<ques id="uk.org.publicwhip/wrans/2010-10-07a.26.1" speakerid="uk.org.publicwhip/lord/100949" speakername="Baroness Coussins" colon=":" colnum="26"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000451">
	<p pid="a.26.1/1" qnum="HL2127">To ask Her Majesty's Government how many students applying to university in each of the past three years had taken (a) French, (b) German, (c) Spanish, (d) Russian, (e) Polish, (f) Mandarin, (g) Arabic, and (h) Turkish, at GCSE and gone on to take that language at AS level; and how many who took each language at AS level went on to take it at A2.</p>
	<p pid="a.26.1/2" qnum="HL2128">To ask Her Majesty's Government how many students applying to university in each of the past three years who had taken two languages at GCSE went on to take (a) one and (b) two languages at AS level.</p>
	<p pid="a.26.1/3" qnum="HL2129">To ask Her Majesty's Government how many students applying to university in each of the past three years who had taken two languages at AS level went on to take (a) one and (b) two languages at A2.</p>
</ques>

<reply id="uk.org.publicwhip/wrans/2010-10-07a.27.0" speakerid="uk.org.publicwhip/lord/100684" speakername="Baroness Wilcox" colon=":" colnum="27"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000398">
	<p pid="a.27.0/1">The information requested is not held centrally and is currently being researched. I will write to the noble Baroness as soon as the information is available and a copy of my letter will be placed in the Library of the House.</p>
</reply>

<minor-heading id="uk.org.publicwhip/wrans/2010-10-07a.27.1" nospeaker="true" colnum="27"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000452">
	Internet: Broadband
</minor-heading>

<ques id="uk.org.publicwhip/wrans/2010-10-07a.27.2" speakerid="uk.org.publicwhip/lord/100549" speakername="Lord Rooker" colon=":" colnum="27"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000452">
	<p pid="a.27.2/1" qnum="HL2110">To ask Her Majesty's Government whether, in light of the report from the Commission for Rural Communities into the potential of upland communities, they have plans to make broadband available to all farmers in upland areas who are willing to participate in schemes to preserve and enhance the landscape.</p>
</ques>

<reply id="uk.org.publicwhip/wrans/2010-10-07a.27.3" speakerid="uk.org.publicwhip/lord/100684" speakername="Baroness Wilcox" colon=":" colnum="27"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000399">
	<p pid="a.27.3/1">The Government are committed to ensuring the UK has the best superfast broadband network in Europe by 2015, including the delivery of superfast broadband to rural and remote areas at the same time as in more populated areas. Farmers in upland communities will be among the beneficiaries of this policy.</p>
</reply>

<minor-heading id="uk.org.publicwhip/wrans/2010-10-07a.27.4" nospeaker="true" colnum="27"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000453">
	Schools: Private Transport
</minor-heading>

<ques id="uk.org.publicwhip/wrans/2010-10-07a.27.5" speakerid="uk.org.publicwhip/lord/100444" speakername="Lord Morris of Manchester" colon=":" colnum="27"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000453">
	<p pid="a.27.5/1" qnum="HL2163">To ask Her Majesty's Government whether the provision of private school transport for children under the age of 18 with special needs will continue to be funded in full by local authorities.</p>
	<p pid="a.27.5/2" qnum="HL2164">To ask Her Majesty's Government whether they will safeguard local authority funding for private school transport for children under the age of 18 with special needs in the forthcoming Comprehensive Spending Review.</p>
</ques>

<reply id="uk.org.publicwhip/wrans/2010-10-07a.27.6" speakerid="uk.org.publicwhip/lord/101010" speakername="Lord Hill of Oareford" colon=":" colnum="27"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000400">
	<p pid="a.27.6/1">Current legislation requires local authorities to make arrangements for those children who:</p>
	<p pid="a.27.6/2">are unable to walk to school because of their special educational needs, disability or mobility problems; orare attending their nearest suitable school (including independent schools, if appropriate) and who live beyond statutory walking distance.</p>
	<p pid="a.27.6/3">Where local authorities consider transport to be necessary, it must be provided free of charge.</p>
	<p pid="a.27.6/4">All funding decisions from 2011 are subject to the outcome of the spending review which will be announced by the Chancellor of the Exchequer.</p>
</reply>

<minor-heading id="uk.org.publicwhip/wrans/2010-10-07a.28.0" nospeaker="true" colnum="28"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000454">
	Taxation: Avoidance
</minor-heading>

<ques id="uk.org.publicwhip/wrans/2010-10-07a.28.1" speakerid="uk.org.publicwhip/lord/100037" speakername="Lord Barnett" colon=":" colnum="28"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000454">
	<p pid="a.28.1/1" qnum="HL2169">To ask Her Majesty's Government what amount of revenue was recouped by action on tax avoidance and tax evasion in (a) 2007-08, (b) 2008-09, and (c) 2009-10.</p>
</ques>

<reply id="uk.org.publicwhip/wrans/2010-10-07a.28.2" speakerid="uk.org.publicwhip/lord/101012" speakername="Lord Sassoon" colon=":" colnum="28"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000403">
	<p pid="a.28.2/1">Total results for tax recovered as a result of HM Revenue and Customs' (HMRC) work to tackle non-compliance in previous years can be found in their departmental autumn performance report 2009, page 40 at Table 4 (<a href="http://www.hmrc.gov.uk/about/autumn-report-2009.pdf">http://www.hmrc.gov.uk/about/autumn-report-2009.pdf</a>). This table shows that the additional tax liability (including penalties and interest) resulting from HMRC compliance work in 2007-08 was &#163;11.051 billion and in 2008-09 was &#163;12.075 billion. Data for 2009-10 are not yet available.</p>
	<p pid="a.28.2/2">As HMRC's performance data are not currently collated on the basis of behaviour, separate figures are not available for avoidance and evasion, and could be produced only at disproportionate cost.</p>
</reply>

<minor-heading id="uk.org.publicwhip/wrans/2010-10-07a.28.3" nospeaker="true" colnum="28"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000455">
	Universities: Finance
</minor-heading>

<ques id="uk.org.publicwhip/wrans/2010-10-07a.28.4" speakerid="uk.org.publicwhip/lord/100983" speakername="Lord Myners" colon=":" colnum="28"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000455">
	<p pid="a.28.4/1" qnum="HL2199">To ask Her Majesty's Government whether they are willing to allow British universities to fail financially; and what action would be taken in such circumstances to protect the financial position of individual students, and to provide continuity of education.</p>
</ques>

<reply id="uk.org.publicwhip/wrans/2010-10-07a.28.5" speakerid="uk.org.publicwhip/lord/100684" speakername="Baroness Wilcox" colon=":" colnum="28"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000405">
	<p pid="a.28.5/1">Universities are autonomous bodies that are responsible for their own financial management. Their financial health is closely monitored by the Higher Education Funding Council for England (HEFCE) which actively assesses and manages risks to financial viability. HEFCE's key interest is in protecting public funds and the interests of students.</p>
</reply>

<minor-heading id="uk.org.publicwhip/wrans/2010-10-07a.28.6" nospeaker="true" colnum="28"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000456">
	Young People: Advice and Guidance
</minor-heading>

<ques id="uk.org.publicwhip/wrans/2010-10-07a.28.7" speakerid="uk.org.publicwhip/lord/100797" speakername="Baroness Morgan of Drefelin" colon=":" colnum="28"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000456">
	<p pid="a.28.7/1" qnum="HL2202">To ask Her Majesty's Government which proposals in <I>Quality, Choice and Aspiration-A Strategy for Young People's Information, Advice and Guidance</I>, issued by the Department for Children, Schools and Families in October 2009, they (a) support, (b) plan to amend, and (c) do not plan to implement.</p>
	<p pid="a.28.7/2" qnum="HL2205">To ask Her Majesty's Government whether it plans to publish a report from the Task Force on the Careers Profession.</p>
</ques>

<reply id="uk.org.publicwhip/wrans/2010-10-07a.29.0" speakerid="uk.org.publicwhip/lord/101010" speakername="Lord Hill of Oareford" colon=":" colnum="29"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000406">
	<p pid="a.29.0/1"><I>Quality, Choice and Aspiration-A Strategy for Young People's Information, Advice and Guidance</I> is a statement of policy made by the previous Government. The coalition Government are currently considering how best to secure high-quality careers guidance for young people and adults alongside the provision of other information, advice and guidance that can help young people navigate the choices they have and will set out more details this autumn. This review of policy will be informed by the recommendations of the Task Force on the Careers Profession. The task force will publish a report this autumn recommending how best to recruit, retain and support careers professionals to provide a high quality service.</p>
</reply>

<minor-heading id="uk.org.publicwhip/wrans/2010-10-07a.29.1" nospeaker="true" colnum="29"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000457">
	Your Freedom Initiative
</minor-heading>

<ques id="uk.org.publicwhip/wrans/2010-10-07a.29.2" speakerid="uk.org.publicwhip/lord/100264" speakername="Lord Grocott" colon=":" colnum="29"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000457">
	<p pid="a.29.2/1" qnum="HL2119">To ask Her Majesty's Government how many responses have been received to their Your Freedom initiative.</p>
</ques>

<reply id="uk.org.publicwhip/wrans/2010-10-07a.29.3" speakerid="uk.org.publicwhip/lord/100908" speakername="Lord Taylor of Holbeach" colon=":" colnum="29"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000407">
	<p pid="a.29.3/1">The Your Freedom website provided an online platform for members of public to suggest laws and regulations that the Government should consider scrapping. It also offered users a forum for commenting and voting on the suggestions of others. At the end of the consultation period there had been 15,238 ideas submitted, 76,994 comments posted and 47,212 registered users.</p>
</reply>

<minor-heading id="uk.org.publicwhip/wrans/2010-10-07a.30.0" nospeaker="true" inserted-heading="true" colnum="30"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000458">
	Your Freedom Initiative
</minor-heading>

<ques id="uk.org.publicwhip/wrans/2010-10-07a.30.1" speakerid="uk.org.publicwhip/lord/100264" speakername="Lord Grocott" colon=":" colnum="30"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000458">
	<p pid="a.30.1/1" qnum="HL2120">To ask Her Majesty's Government whether they have plans to publish responses to the Restoring Civil Liberties section of the Your Freedom initiative indicating the laws which respondents want removed or changed and the number supporting each proposition.</p>
</ques>

<reply id="uk.org.publicwhip/wrans/2010-10-07a.30.2" speakerid="uk.org.publicwhip/lord/100908" speakername="Lord Taylor of Holbeach" colon=":" colnum="30"  url="http://www.publications.parliament.uk/pa/ld201011/ldhansrd/text/101007w0001.htm#10100715000408">
	<p pid="a.30.2/1">The process of analysing ideas submitted to the Your Freedom website is ongoing. The Government have always stated that every idea will be given due consideration, but it cannot guarantee a response to each one.</p>
	<p pid="a.30.2/2">The majority of the ideas submitted to the website relating to the Restoring Civil Liberties section are the responsibility of the Home Office. Whilst some ideas, such as legalising drugs, will not be taken forward by this Government, many of the public's comments will be included in the Freedom Bill or in other legislation to be introduced later this Session. For example, we have already announced that a ban on wheel clamping on private land and changes to DNA retention policy will be introduced in the Freedom Bill.</p>
</reply>
</publicwhip>

